Drug clinical trial landscape of chronic myeloid leukemia: achieving the endpoint or continuing the journey?

Drug clinical trial landscape of chronic myeloid leukemia: achieving the endpoint or continuing the journey?

Saved in:

Bibliographic Details
Main Authors:	Shiyu Yang, Xia Jiang, Haihui Zhuang, Fenglin Li, Ying Lu
Format:	Article
Language:	English
Published:	BMC 2024-11-01
Series:	Journal of Translational Medicine
Online Access:	https://doi.org/10.1186/s12967-024-05882-5
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Epigenetic Landscape of Acute Myeloid Leukemia
by: Emma Conway O’Brien, et al.
Published: (2014-01-01)

Key principles of drug therapy in patients with chronic myeloid leukemia
by: A. V. Zhuravlev, et al.
Published: (2023-07-01)

Genetic landscape of acute myeloid leukemias with leukocytosis
by: K. A. Pekhova, et al.
Published: (2023-09-01)

Chronic myeloid leukemia in India
by: John M Goldman
Published: (2013-01-01)

Factors associated with achievement and durability of cytogenetic response in patients with chronic myeloid leukemia treated with imatinib
by: Ćojbašić Irena, et al.
Published: (2011-01-01)

Glycolysis-Driven Prognostic Model for Acute Myeloid Leukemia: Insights into the Immune Landscape and Drug Sensitivity
by: Rongsheng Zhang, et al.
Published: (2025-03-01)

Cost effectiveness of therapeutic drug monitoring for imatinib administration in chronic myeloid leukemia.
by: Kibum Kim, et al.
Published: (2019-01-01)

Retinal infiltration by chronic myeloid leukemia
by: Maïlys Charmasson, et al.
Published: (2025-03-01)

TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
by: Michele Baccarani, et al.
Published: (2014-01-01)

Acute Myeloid Leukemia with NUP98: : LNP1 Fusion Mimicking Chronic Myeloid Leukemia
by: Haiyang Wang, et al.
Published: (2025-06-01)

METABOLIC STATE OF BLOOD LYMPHOCYTES IN CHRONIC MYELOID LEUKEMIA AND CHRONIC LYMPHOID LEUKEMIA
by: O. V. Smirnova, et al.
Published: (2014-07-01)

Endpoints in Heart Failure Drug Development
by: Aliza Hussain, et al.
Published: (2022-01-01)

MOLECULAR BIOLOGY AND DRUG THERAPIES OF CHRONIC MYELOID LEUKEMIA: A REVIEW OF RECENT LITERATURE
by: Sameen Shahid, et al.
Published: (2024-03-01)

Dasatinib Dose Optimization Based on Therapeutic Drug Monitoring in Patients with Chronic-Phase Chronic Myeloid Leukemia
by: Cheng F, et al.
Published: (2025-05-01)

Cytokine profile in patients with chronic myeloid leukemia
by: T. N. Aleksandrova, et al.
Published: (2024-01-01)

Pseudohyperkalemia in a patient with chronic myeloid leukemia
by: Madelene Jacobsz, et al.
Published: (2007-07-01)

Use of dasatinib in chronic myeloid leukemia therapy
by: O. Yu. Vinogradova, et al.
Published: (2008-12-01)

A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
by: Michele Baccarani, et al.
Published: (2013-12-01)

Priapismus as Leukostasis Manifestation in Chronic Myeloid Leukemia
by: Wulyo Rajabto, et al.
Published: (2020-12-01)

Priapismus as Leukostasis Manifestation in Chronic Myeloid Leukemia
by: Wulyo Rajabto, et al.
Published: (2020-12-01)

Hypercalcemia in Chronic Myeloid Leukemia: An Unusual Presentation
by: Khushboo Agarwal, et al.

Epidemiology of Chronic Myeloid Leukemia in the Republic of Bashkortostan
by: NR Ryabchikova, et al.
Published: (2018-10-01)

Chronic myeloid leukemia data from India
by: Shweta Bansal, et al.
Published: (2013-01-01)

Synchronous Occurrence of Chronic Myeloid Leukemia and Mantle Cell Lymphoma
by: Prajwol Pathak, et al.
Published: (2017-01-01)

Sarcopenia in Ageing and Chronic Illness: Trial Endpoints and Regulatory Issues
by: Stephan vonHaehling, et al.
Published: (2025-06-01)

Optimizing olverembatinib dose in chronic phase chronic myeloid leukemia
by: Xiaoshuai Zhang, et al.
Published: (2025-04-01)

Selection of Endpoints for Clinical Studies of Ophthalmic Drugs
by: M. O. Komarova
Published: (2021-10-01)

Clinical Trial Risk in Hepatitis C: Endpoint Selection and Drug Action
by: Nicole A. Tillie, et al.
Published: (2016-01-01)

The Role of Bosutinib in Chronic Myeloid Leukemia: An Indian Perspective
by: Mohan Bajranglal Agarwal, et al.
Published: (2024-08-01)

The role of METTL14 in the progression of chronic myeloid leukemia
by: Jing Zhang, et al.
Published: (2025-12-01)

CLINICAL AND PATHOMORPHOLOGICAL EXAMINATION OF MYELOFIBROSIS IN CHRONIC MYELOID LEUKEMIA
by: T. Yu. Dolgikh, et al.
Published: (2016-02-01)

Chronic myeloid leukemia in childhood: a case report
by: Uma Bhatta, et al.
Published: (2021-09-01)

Intracerebral Granulocytic Sarcoma in recurrence of Chronic Myeloid Leukemia
by: Angelo Borsarelli Carvalho Brito, et al.
Published: (2015-01-01)

Mathematical modeling of cyclic treatments of chronic myeloid leukemia
by: Natalia L. Komarova
Published: (2011-03-01)

CNS Involvement in a Patient with Chronic Myeloid Leukemia
by: Marcus A. Healey, et al.
Published: (2021-01-01)

Olverembatinib in chronic myeloid leukemia: is less actually better?
by: Maria Agustina Perusini, et al.
Published: (2025-06-01)

ONE CASE OF CHRONIC MYELOID LEUKEMIA IN PEDIATRIC GROUP
by: Nihal Boz
Published: (2024-12-01)

An interesting case of chronic myeloid leukemia with twists and turns
by: Thulasi Raman Ramalingam, et al.
Published: (2024-12-01)

Research status and advances in immunotherapy for chronic myeloid leukemia
by: WANG Mengmeng, et al.
Published: (2025-05-01)

Clinical Recommendations for the Diagnosis and Treatment of Chronic Myeloid Leukemia
by: AG Turkina, et al.
Published: (2017-07-01)